{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:14:21Z","timestamp":1782886461678,"version":"3.54.5"},"reference-count":15,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1210\/js.2018-00010","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T17:50:12Z","timestamp":1523037012000},"page":"437-443","source":"Crossref","is-referenced-by-count":13,"title":["Fibroblast Growth Factor 23\u2013Induced Hypophosphatemia in Acute Leukemia"],"prefix":"10.1210","volume":"2","author":[{"given":"Rachel B","family":"Reinert","sequence":"first","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Bixby","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J","family":"Koenig","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"issue":"3","key":"2019041122572960900_B1","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"2019041122572960900_B2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"key":"2019041122572960900_B3","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2019041122572960900_B4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/ajcp\/aqx111","article-title":"Philadelphia chromosome-like mixed-phenotype acute leukemia demonstrating P2RY8-CRLF2 fusion and JAK1 mutation","volume":"148","author":"Choi","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"2019041122572960900_B5","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811","volume":"85","author":"Larson","year":"1995","journal-title":"Blood"},{"issue":"3","key":"2019041122572960900_B6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J Clin Oncol"},{"issue":"15","key":"2019041122572960900_B7","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quint\u00e1s-Cardama","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2019041122572960900_B8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2019041122572960900_B9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","article-title":"Cinacalcet in the management of tumor-induced osteomalacia","volume":"22","author":"Geller","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2019041122572960900_B10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"key":"2019041122572960900_B11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bonr.2015.11.004","article-title":"Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: a case report and review of the literature","volume":"5","author":"Abate","year":"2016","journal-title":"Bone Rep"},{"key":"2019041122572960900_B12","doi-asserted-by":"crossref","first-page":"bcr2015213954","DOI":"10.1136\/bcr-2015-213954","article-title":"Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin\u2019s lymphoma","volume":"2016","author":"Elderman","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2019041122572960900_B13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bone.2006.01.163","article-title":"Elevated serum FGF23 concentrations in plasma cell dyscrasias","volume":"39","author":"Stewart","year":"2006","journal-title":"Bone"},{"issue":"2","key":"2019041122572960900_B14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9343(87)90081-7","article-title":"Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia","volume":"82","author":"Rao","year":"1987","journal-title":"Am J Med"},{"issue":"11","key":"2019041122572960900_B15","doi-asserted-by":"crossref","first-page":"1437.e3","DOI":"10.1016\/j.ajem.2014.04.011","article-title":"Life-threatening hypophosphatemia and\/or phosphate depletion in a patient with acute lymphoblastic leukemia: a rare case report","volume":"32","author":"Soyoral","year":"2014","journal-title":"Am J Emerg Med"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/2\/5\/437\/24692958\/js.2018-00010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T11:21:15Z","timestamp":1571052075000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/2\/5\/437\/4963538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,6]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2018-00010","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,4,6]]}}}